High-Impact International Trials

One of the key objectives of the ACT Consortium is to expand Canadian participation in international trials. This new funding opportunity is designed to:

(1) support ongoing and active, internationally led, high-impact randomized controlled trials (RCTs);

(2) bring such trials to Canada so Canadian patients can have access to participate; and

(3) have National Canadian Principal Investigators and Canadian Site Investigators contribute to an important internationally led trial and build international collaborations.

Applicants can request up to $200,000 to support the recruitment of Canadian participants in their high-impact, ongoing international RCT.